# Histopathology of Diabetic Nephropathy: Beyond Glomerular Basement Membrane Thickening

**Authors:** Hussein Qasim, Shaima' Dibian, Anas Hayajneh, Karis Khattab, Matteo Luigi Giuseppe Leoni, Giustino Varrassi

PMC · DOI: 10.7759/cureus.93497 · Cureus · 2025-09-29

## TL;DR

This review explores the complex histopathology of diabetic nephropathy beyond just glomerular changes, emphasizing the need for accurate diagnosis and new treatment strategies.

## Contribution

The paper provides a comprehensive overview of the evolving histopathological understanding of diabetic nephropathy.

## Key findings

- Diabetic nephropathy involves multiple kidney compartments, not just glomerular changes.
- Tubulointerstitial, vascular, and podocyte pathology are critical components of the disease.
- Emerging biomarkers and imaging techniques may improve early detection and risk assessment.

## Abstract

Diabetic nephropathy (DN) is a leading cause of chronic kidney disease and end-stage renal disease worldwide, characterized by progressive injury across all renal compartments. Traditionally considered a glomerular disorder marked by basement membrane thickening, mesangial expansion, and nodular sclerosis, DN is now recognized as a multifaceted process involving tubulointerstitial, vascular, and podocyte pathology. This narrative review integrates current histopathological insights, highlighting key glomerular lesions, tubular basement membrane thickening, interstitial fibrosis, arteriolar hyalinosis, and podocyte injury, as well as atypical and advanced patterns. The role of kidney biopsy in diagnosis, the application of the Renal Pathology Society classification, and differentiation from mimicking conditions such as amyloidosis and monoclonal deposition disease are discussed. Emerging biomarkers and advanced imaging modalities offer promise for earlier detection and risk stratification. Understanding the full histological spectrum of DN is critical for accurate diagnosis, prognostication, and the development of targeted therapies. Future directions include molecular classification, non-invasive diagnostics, and precision medicine approaches to improve patient outcomes.

## Linked entities

- **Diseases:** Diabetic nephropathy (MONDO:0005016), chronic kidney disease (MONDO:0005300), end-stage renal disease (MONDO:0004375), amyloidosis (MONDO:0019065)

## Full-text entities

- **Diseases:** end-stage renal disease (MESH:D007676), amyloidosis (MESH:D000686), monoclonal deposition disease (MESH:D004194), glomerular disorder (MESH:D007674), chronic kidney disease (MESH:D051436), nodular sclerosis (MESH:D008224), DN (MESH:D003928), fibrosis (MESH:D005355)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12571060/full.md

## References

160 references — full list in the complete paper: https://tomesphere.com/paper/PMC12571060/full.md

---
Source: https://tomesphere.com/paper/PMC12571060